A clinical study for evaluating of the effect of a complex food on postprandial serum triglyceride. - Clinical study for the effect on TG

Iryouhoujinsyadan Shoureikan Shinsapporo Seiryou Hospital0 sites40 target enrollmentNovember 29, 2018

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: Iryouhoujinsyadan Shoureikan Shinsapporo Seiryou Hospital
Enrollment: 40
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

November 29, 2018

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Iryouhoujinsyadan Shoureikan Shinsapporo Seiryou Hospital

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects with hepatic, renal, cardiac or organ disorders or diabetes or other serious diseases. (2\) Subjects with a surgical history of digestive system (except appendicectom). (3\) Subjects with a history of a previous drug or food allergy. (4\) Subjects currently under treatment with chronic diseases. (5\) Subjects who are pregnant or intend to become pregnant during the study or are lactating. (6\) Subjects who are lactose intolerant or sensitive to fatty diet to show gastrointestinal symptoms. (7\) Subjects who take excessive alcohol (equivalent to 540 mL of Japanese sake or more) for 5 days or more per week. (8\) Subjects who take drugs or supplements which claim the suppressive absorption of sugar or lipid or reduction of triglyceride, etc. (9\) Subjects who participate in other clinical trial. (10\) Subjects who have a history of feeling ill or unwell during or after blood drawing. (11\) Subjects who have donated over 200 mL of blood within the last one month prior to this study or expect to donate the same during the study. (12\) Subjects with extremely irregular dietary life (shift worker, night\- shift worker, etc.) (13\) Subjects who had excessive eating and/or drinking during 3 days prior to each screening or prior to intervention period I or II. (14\) Subjects who fasted repeatedly during 3 days prior to each screening or prior to intervention period I or II. (15\) Subject who had excessive exercise than usual during 3 days prior to each screening or prior to intervention period I or II. (16\) Subjects judged as unsuitable for this study by the investigator for other reasons.